16:09 EST Nektar (NKTR) files automatic mixed securities shelf
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NKTR:
- Nektar Therapeutics Reveals Promising Phase 2b Trial Results
- Nektar presents new data from REZOLVE-AD study of ACAAI
- Nektar Therapeutics’ Earnings Call Highlights Robust Growth and Innovation
- Nektar Therapeutics Reports Q3 2025 Financial Results
- Hold Rating on Nektar Therapeutics Amid Uncertainties in Rezpeg’s Clinical Trials and Market Potential